Website highlights

Recent news

Public disclosure of biological sequences in global patent practice

World Patent Information, USA
December 1, 2015
A global Patent Sequence (PatSeq) Data platform can enable national and regional jurisdictions meet the public disclosure standards.

The ownership question of plant gene and genome Intellectual properties

Nature Biotechnology, USA
November 1, 2015

Gene patent practice across plant and human genomes

Nature Biotechnology, USA
October 8, 2015
Similarities and differences in gene patent practices across three major crop and human genomes are exposed

More news from Cambia

Meet the team

We have highly skilled teams of Intellectual Property, Informatics and Molecular Biology experts with excellent administrative and executive support.

Find out more about our team


What are we looking for in a job applicant?

We're not looking to put square pegs in round holes, but we're looking for dynamic, self-motivated, disciplined and imaginative colleagues.

We want people who understand what we're doing, find a major role for themselves, and convince us that what they can do must be done and they must be involved in doing it with us.

We really value professionalism, competence and energy. We set the bar very high - the challenge is not an institutional one, but a systemic one. There are major forces in play in the world that need well crafted alternatives - not polemic, but practical. We are in a critical time and place to make a real difference. Convince yourself that you have the skills to help do that and that doing so matters enough to you; then convince us, and we can proceed from there.

Read the website, our press pages, and documents that are available to download. If you see a powerful way that you can be part of our team and can anticipate what we need to promote real structural reform in innovation, then contact us. Send us an e-mail with your CV and a letter explaining how you can meet our needs and contribute to our goals.


We have no open funded positions at this time.

Comments (0)